The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Daily Archives: April 23, 2017
Adam and the Genome– Part Five – Patheos – Patheos (blog)
Posted: April 23, 2017 at 12:24 am
Modern evolutionary science, including the science of genetics is based on the hypothesis that most if not all things can be explained in a natural way through empirical research. A theist evolutionist will simply say that evolution is the way God works things. Suppose however that God is not like a watchmaker who creates a watch, winds it up, and leaves it to the empirical parts to do their jobs their after? Suppose God is constantly involved not merely in human history but in all things great and small. Suppose the designer constantly has his hand on the design, and makes changes and modifications? Suppose he designed human beings to be like other higher order creatures so that humans would feel some kinship with them, and take care of them, and be good governors of Gods creation? Evolution is a theory that leave God constantly out of the equation, or alternately simply says this is the natural mechanism God chose to accomplish things.
The same problems arise in applying this sort of information to the historical figures of Adam and Eve as arises in the neuro-scientific discussions about the mind and the brain, where the assumption is that human beings are psychosomatic wholes, and as such, when the body goes the whole person dies. There is no human spirit, human personality that survives death. Of course, no scientist has gone to the other side of death and done an empirical study of whether there might be spirits of the departed in heaven or elsewhere. The assumption again is this world, this life, these natural processes, like evolution are all there is, and so a theory which explains some things, is globalized to explain everything, including ruling out ongoing divine action in the natural and human worlds, never mind ruling out the afterlife.
My point by drawing attention to these two differing attempts at discussing science and the Bible together is that science often has to extrapolate or theorize from the known to the unknown to come up with a purely materialistic and empirical explanation for things.
See the rest here:
Adam and the Genome-- Part Five - Patheos - Patheos (blog)
Posted in Genome
Comments Off on Adam and the Genome– Part Five – Patheos – Patheos (blog)
CRISPR genome editing and immunotherapy the early adopter … – Cancer Research UK (blog)
Posted: at 12:24 am
Its been a couple of years since the genome editing tool CRISPR first hit the headlines. And talk of its potential to cure all manner of diseases, create superhumans and bring dinosaurs back from the dead has followed.
But among that speculation, one area of medicine has been quick to pick up the technology and is now leading the way in early clinical trials.
In this second post in our series taking a closer look at CRISPR, we explore its potential for new developments in cancer immunotherapy.
Immunotherapy can take a range of forms. Some experimental approaches use viruses that kill cancer cells and alert the immune system to attack. Others involve giving patients drugs that release the brakes on immune cells to target cancer. And some use specially engineered immune cells that when injected into a patient have the potential to hunt out and kill cancer cells.The aim of immunotherapy treatments is to alert the bodys immune system to cancer, so that its better equipped to recognise and fight the disease.
In each of these cases, scientists need to be able to understand and fine-tune the bodys complex immune system. And some are turning to CRISPR for help.
Dr Martin Pule, a clinical senior lecturer in haematology at UCL, says that genome editing techniques such as CRISPR have quickly become part of the tool-kit for researchers like him.
In the past, many of the technical problems around introducing new genes into cells were worked out, but we didnt have an easy way of efficiently and precisely disrupting existing genes, he says. New genome editing technologies changed all that.
By using CRISPR, scientists are able to tweak specific genes in viruses or the bodys own immune cells, and so make them behave differently.
Researchers have been able to do this before using similar techniques, but the excitement around CRISPR is that this can be done much quicker, cheaper and more precisely than ever before.
Genome editing techniques have been used in people to treat cancer and other diseases before.
There was lots of excitement when news broke in 2015 of a 1 year old girl with acute lymphoblastic leukaemia (ALL) being treated with a similar editing technique known as TALENs, after all other treatments had failed.
She received a transplant of cancer-fighting immune T cells from a donor, which had been tweaked in the lab to give them 2 new characteristics.
Normally, the donated cells would see their new environment as foreign and attack the patients healthy cells, but genes that control this process were turned off. The T cells would also be susceptible to attack from the anti-cancer drugs that the baby was receiving, and so modifications were made to protect them.
She responded well to the treatment, and another infant received a similar therapy.
Following in the footsteps of its cousin TALENs, CRISPR itself has moved on from the lab to clinical trials. Late last year, a Chinese group became the first to use CRISPR-edited cells in humans.
Find out more:9 burning questions about CRISPR genome editing answered
The team took immune cells from a patient with an aggressive lung cancer and edited them in the lab. This editing deactivates a gene that allows tumours to put the brakes on these immune cells, preventing them from attacking cancer cells.
By switching off the gene, which produces a molecule on the cells surface called PD-1, the full force of the bodys immune system is released, helping it clear the tumour. Drugs that target PD-1 are among the much-lauded immunotherapy treatments already showing promise in advanced melanoma and lung cancers. So theres a lot of hope that CRISPR may provide another step forward here too.
10 patients will be involved in the early-stage Chinese trial, and it will look at whether the treatment is safe, rather than testing effectiveness.
The scientists are also hoping to start clinical trials using CRISPR to treat bladder,prostateandkidney cancers. Its also positive news that both blood cancers and solid tumours appear to be responding to various immunotherapy approaches, as different challenges are faced in treating these diseases.
One clever immunotherapy trick fuses together 2 components of the immune system with different jobs.
Chimeric antigen receptor (CAR) T cells are a mix of an antibody molecule, which can home in on a specific target on tumour cells, fused to a T cell that provides the knock-out blow to the cancer cell.
Weve blogged before about how these engineered cells work, and small trials in 2011 caused lots of excitement. But one of the latest updates is that using CRISPR instead of older genome editing techniques might supercharge these CAR T-cells even further.
The older technology is less precise and can result in the genes mistakenly being inserted at random locations in the cells DNA. The knock-on effect is that the engineered cells might be less effective or unintended side-effects could be introduced.
But a US-based group found that CRISPR improved the precision with which the modified gene was inserted into T cells. Their research suggests that the cells were then more potent in their fight against leukaemia in mice because they had more stamina. The researchers are now hoping to test these findings in people.
Cancer cells are relentless in their attempt to evade treatment, so we need CAR T cells that can match and outlast them, Dr Michel Sadelain, the researcher leading the study at Memorial Sloan Kettering Cancer Center, said at the time.
Find out more:Engineering a cancer-fighting immune super soldier
Its findings like these that will hopefully make engineered immune cell treatments better and kinder in the future, though they arent yet the Holy Grail.
In one kind of leukaemia called B-ALL, almost 100% of children who received engineered T cells responded, despite having a disease which had become resistant to all standard treatments, says Pule.
This suggests that, in some circumstances, there may not be an upper limit on who may respond to these treatments. But achieving this in other cancers will take further fine-tuning. In other diseases, such as another kind of blood cancer called DLBCL, the response rates are more like 60%.`
This reflects the fact that a good CAR T cell product is hard to make, or that there are factors inside the tumour making the T cells less effective, Pule adds.
Lots of the progress using CAR T cells has so far been in blood cancers rather than solid tumours, which have even tougher conditions.
Because CRISPR allows scientists to do lots of small-scale tinkering, this is a rapidly developing field and researchers are trying to find solutions.
Right now a lot of people are asking why theres this response gap between DLBCL and B-ALL. Can we edit something in the CAR T cell, or put something extra in which will increase the response rates?
One reason might be that the tumour lives in a hostile environment that stops the engineered T-cells ability to attack the cancer cells. One way around this is to delete the molecules on T cells that coordinate the stop messages from the microenvironment.
This strategy looks like it might be quite effective and could increase the number of patients who respond, says Pule.
Some of the research thats taken place since CRISPR burst onto the scene has also raised more questions than answers. The immune system is a powerful and complicated machine, and we dont yet understand how to control it.
Not all of these treatments have been as successful as hoped. As well as varying response rates, they can also cause serious side effects, including, in rare cases, death.
There have been recent reports of patients with bladder cancer whose tumours increased in size after immunotherapy treatment, although this has caused some debate among researchers. Side effects including extreme fever or organ damage have also been well documented in clinical trials.
In the US, a total of 5 patients died following treatment with an experimental CAR T cell therapy for ALL. The clinical trial was paused after 3 people died, and then stopped after 2 more deaths.
While this is very rare, its clear that as well as working to make treatments more effective in more people, researchers also need to look at how they can reduce side effects.
Similar problems were seen in the past in the early days of treatments such as combination chemotherapy, before they were refined.
Pule points to how scientists are already using genome editing to increase safety. For example, in many cases, it isnt possible to engineer a patients own T cells and so cells from a donor are needed.
But this raises some challenges.
The donor T cells might attack the recipient causing graft-versus-host disease, says Pule. Graft-versus-host disease is a condition where the donor cells see their new environment as foreign and attack it. If we remove a specific molecule in the donor T cells using gene-editing technology, we can reduce the chance of this happening.
This is how the two infants with ALL were treated.
Like many new technologies, CRISPR was greeted with excited fanfare in some parts, and a more cautious realism is now settling in.
Its clear that CRISPR opens up so many doors for immunotherapy and lets researchers go further, more easily than ever before. But as the technology is understood better, its limitations and challenges also come into focus.
The third part of our CRISPR series will take a look at what the future might hold for CRISPR and cancer research.
Michael
The rest is here:
CRISPR genome editing and immunotherapy the early adopter ... - Cancer Research UK (blog)
Posted in Genome
Comments Off on CRISPR genome editing and immunotherapy the early adopter … – Cancer Research UK (blog)
At 117, world’s oldest woman works hard and avoids pork – Greensboro News & Record
Posted: at 12:24 am
DUANVALE, Jamaica Violet Brown spent much of her life cutting sugarcane in the fields around her home in western Jamaica. She attended church regularly, avoids pork and chicken and celebrated her 117th birthday last month.
On Saturday, she is believed to have become the world's oldest living person following the death of Emma Morano of Italy, born Nov. 29, 1899.
Brown told The Associated Press she is surprised but grateful to have lived this long.
"This is what God has given me, so I have to take it long life," Brown said in an interview in her home in the town of Duanvale.
Brown is considered to be the oldest person in the world with credible birth documentation, according to Robert Young, director of the supercentenarian research and database division at Gerontology Research Group, a network of volunteer researchers into the world's oldest people. Its website says she was born on March 10, 1900.
Brown has not yet been declared the world's oldest by Guinness World Records, considered to be the official arbiter of the oldest person title but Guinness depends heavily on Young's group. Young said he has met Brown and examined her birth certificate, which was issued by the British authorities who governed Jamaica at the time of her birth.
"She's the oldest person that we have sufficient documentation for at this time," Young said.
Jamaica's prime minister congratulated Brown on Twitter.
Guinness said it was researching a number of candidates for the new world's oldest person title.
"It can be a uniquely complex and sometimes lengthy process," Guinness spokeswoman Elizabeth Montoya said. "There is no confirmation of a new title holder until our thorough processes are complete."
Brown has two caregivers and spends most of the day resting in the home she shares with her 97-year-old son. She is able to sit up by herself and walk short distances. And while she is hard of hearing, she offered swift, complete responses to questions about her life and family.
The secret to long life is hard work, she said.
"I was a cane farmer. I would do every work myself," she said. "I worked, me and my husband, over that hill."
She also credited her Christian faith for her long life.
"I've done nearly everything at the church," she said. "I spent all my time in the church. I like to sing. I spent all my time in the church from a child to right up," to today, she said.
Read more here:
At 117, world's oldest woman works hard and avoids pork - Greensboro News & Record
Posted in Human Longevity
Comments Off on At 117, world’s oldest woman works hard and avoids pork – Greensboro News & Record
Hundreds in Athens join worldwide marches for science – Online Athens
Posted: at 12:24 am
Maybe it wasnt exactly scientifically confirmed, but it was nonetheless clear that Saturdays March for Science in downtown Athens not a march, exactly, as things turned out exceeded the limits of the police-issued permit for the event in front of the federal courthouse on Hancock Avenue.
I think weve broken the law, folks! an exuberant Mark Farmer, a cellular biologist at the University of Georgia, told the crowd jamming the courthouse lawn from the steps into the street.
Because the local March for Science part of hundreds of such marches held around the world on Earth Day coincided with the popular G-Day intrasquad University of Georgia football game that brings thousands of visitors to town, organizers couldnt get a parade permit for downtown Athens, according to Farmer.
Instead, they were granted a permit to rally on the federal courthouse grounds outside the heaviest G-Day traffic from 11 a.m. until noon, with a limit of 400 people. But one glance around the crowded lawn made it clear that the actual number of people was well above that limit, with one estimate placing the crowd at 600 people or more, who waved signs and chanted as a line of speakers extolled the human progress made possible by science.
And, with a little lighthearted civil disobedience in his heart, as the rally was winding down Saturday morning, Farmer looked at the permit and said, I see nothing on here saying you cant all take your signs and walk downtown!
The Athens event and those held worldwide were aimed at promoting an understanding of science and defending science from issues such as proposed federal government budget cuts that could adversely affect scientific research in this country.
Waving signs with slogans like Grab them by the data and Science is not a liberal conspiracy, the hundreds of people who attended the March for Science in downtown Athens heard from a number of speakers including Marilyn Williams, the director of spiritual care at St. Marys Hospital in Athens.
Prior to becoming a chaplain, Williams worked for two decades in cancer research and health care management, and she spoke Saturday about the nexus between science and religion.
Theres no conflict between the two, she said. Both are just different approaches for understanding our world.
And, Williams said, pastoral care work shows the connection between faith and science.
We really do see where science and faith come together, she said. Theyve always been connected.
Also speaking Saturday was Kathy Fowler, a veterinarian and march organizer who suggested to the crowd that without science particularly the medical research that has improved human health and longevity many of the people at Saturdays march might not have been there.
The scientific discoveries of the the last few centuries are what allowed you to be here today, she said.
Human health has also been improved by scientific advancements in water quality and in properly handling wastewater, Fowler continued.
They all came about because of scientific research and discovery, she said.
The local focus on science will continue in neighboring Oconee County on Sunday, where the Oconee County Democrats will host a nonpartisan event called Walk and Talk with a Scientist.
The walk is scheduled for 3 to 5 p.m. at Herman C. Michael Park off Georgia Highway 53 and Elder Road. Scientists will gather at the walking trail, which is paved and about a third of a mile long.
People can choose a scientist and walk the trail with them while talking about that persons scientific investigations or study. Among the scientists participating in the event are a geologist, an expert in water toxicity, a botanist, a specialist in endangered species and an expert on coral reefs.
Across the United States on Saturday, one of the organizers of the first Earth Day, Denis Hayes, said the crowd he saw on the National Mall in Washington appeared energized and magical, almost like what he saw on the first Earth Day 47 years ago.
Hundreds turned out in light rain for a pro-science rally on the Vermont Statehouse lawn in Montpelier. One of the speakers, Rose Paul, director of conservation science for The Nature Conservancy of Vermont, told the crowd that Science is not a partisan issue. She said climate change is happening and scientists are needed to help understand how shifting weather patterns are affecting the world.
In Nashville, Tenn., hundreds of people braved pouring rain, marching through city streets and chanting science, not silence.
President Donald Trump said in an Earth Day statement that his administration is committed to keeping our air and water clean, to preserving our forests, lakes and open spaces and to protecting endangered species.
But that wont be done, he said, in a way that harms working families, and he added that the government is reducing unnecessary burdens on American workers and American companies, while being mindful that our actions must also protect the environment.
The Associated Press contributed to this report.
Read the original post:
Hundreds in Athens join worldwide marches for science - Online Athens
Posted in Human Longevity
Comments Off on Hundreds in Athens join worldwide marches for science – Online Athens
Human Umbilical Cord Blood Helps Aging Mice Remember, Study Finds – NPR
Posted: at 12:24 am
Researchers found that a protein in human umbilical cord blood plasma improved learning and memory in older mice, but there's no indication it would work in people. Mike Kemp/Rubberball/Getty Images hide caption
Researchers found that a protein in human umbilical cord blood plasma improved learning and memory in older mice, but there's no indication it would work in people.
Decades ago, scientists surgically attached pairs of rats to each other and noticed that old rats tended to live longer if they shared a bloodstream with young rats.
It was the beginning of a peculiar and ambitious scientific endeavor to understand how certain materials from young bodies, when transplanted into older ones, can sometimes improve or rejuvenate them.
From the beginning, the findings were exciting, complex and, sometimes, contradictory. For example, scientists have shown that young blood can restore cell activity in the muscles and livers of aging mice. They've also found that linking old mice to young ones helped reverse heart muscle thickening.
On the other hand, researchers weren't able to replicate some of the most eye-catching findings and another study concluded that, in mice that swapped blood without being connected surgically, the negative effects of being exposed to old blood outweighed the benefits of getting young blood.
What was clear was that, like humans, as mice age their bodies and their behavior change on a fundamental level. For example, older mice stop building nests, and they tend to become forgetful, taking a long time to remember how to escape from a maze.
"We see a pretty dramatic difference between young and aged mice in terms of their performance," says Joe Castellano, a neuroscientist at Stanford University School of Medicine.
Castellano and his colleagues wondered if young human blood might have beneficial effects for aging mice.
Now, they report in the journal Nature that they've found a protein in human umbilical cord blood that improved learning and memory in aging mice. It's an exciting find in the field of regenerative medicine.
But, scientists caution, it does not mean people should start ordering umbilical cord blood online. There is no indication that it would work in humans.
For their study, Castellano and his colleagues collected plasma, which is the watery part of blood, from people of different ages. Some were in their 60s and 70s, others in their 20s. They also collected plasma from human umbilical cords.
Then, they injected human plasma from those different age groups and from umbilical cord blood into mice several times over the course of a couple of weeks.
The mice were 12 and 14 months old, which is approximately the mouse equivalent of being in your late 50s or 60s.
When they dissected the mouse brains and inspected the hippocampi, they found that certain genes linked to making new memories had been turned on in some of the mice.
"So, we had a hint early on that one of these donor groups, specifically the [umbilical] cord plasma, might be having an effect on the brain itself," he says.
Next, they injected more aging mice with human plasma and tested the animals' ability to remember things.
For example, they watched how long it took the mice to escape from a maze the mice had done before, using visual cues to choose an exit that would lead to safety.
Castellano says it's basically like observing a person try to navigate through a crowded garage to locate their parked car.
Before being injected with umbilical cord blood, Castellano says, "their performance wasn't very impressive." It took them a long time to learn and remember the location of the escape hole, and some of them didn't manage at all. "But after cord plasma treatment, both the time [it took to] find it, the rate at which they'd find it and the fact that they do find it was improved and changing," he says.
Similarly, mice treated with human umbilical cord blood performed better on a second memory test. That test involved introducing mice to a chamber and then delivering a little shock to their feet. Mice that remembered the unpleasant experience would, when reintroduced to the chamber, freeze in anticipation of the shock. A forgetful mouse, on the other hand, would go about its usual business.
Castellano says the mice that had received umbilical cord plasma froze more often.
"We were, first of all, surprised and excited that there was something in human plasma, and more specifically there's something exciting about cord plasma," he says.
After a series of other experiments, Castellano and his colleagues concluded that one protein, called TIMP2, in human umbilical cord blood was likely responsible for the improvement.
When they removed TIMP2 from cord plasma and injected the plasma into mice, they didn't observe any improvement on the memory tests. And when they injected plasma containing TIMP2 into elderly mice, they again observed improvement in memory and learning tasks.
"The really exciting thing about this study, and previous studies that have come before it, is that we've sort of tapped into previously unappreciated potential of our blood our plasma and what it can do for reversing the harmful effects of aging on the brain," says Castellano.
It's an intriguing hint at how potential therapies might someday work to prevent age-related illness, including Alzheimer's disease, from developing.
"The desired outcome is overall whole body rejuvenation," says Aubrey de Grey, a biomedical gerontologist who founded the SENS Research Foundation.
The study by Castellano and colleagues, he says, is an "excellent" starting point.
"The only thing, of course, is that it's a mouse experiment and mouse experiments often don't actually translate faithfully into the human setting," he says.
And Castellano agrees that this finding does not mean that people should start sprinkling TIMP2 protein on their cereal or signing up for umbilical cord transfusions.
First off, he says, there's no evidence that elderly humans would experience the same effects as the mice did in this study. It's also unclear what would happen to mice if they received the plasma for more than just a few weeks.
There's also the nagging worry that, while proteins like TIMP2 may be beneficial for developing babies, they could be harmful in older humans.
"Maybe there's a reason that older brains aren't exposed to certain proteins any longer," says Castellano.
And Irina Conboy, who studies aging and degenerative diseases at the University of California, Berkeley, points out that the TIMP2 protein is actually present in higher levels in people with Alzheimer's disease.
That runs counter to the argument made by Castellano and colleagues that TIMP2 is associated with improved memory and learning, and that TIMP2 levels would drop as people age.
"TIMP2 is a very well-known protein," she says. She also notes that one of Castellano's co-authors, Tony Wyss-Coray, is the board chair for a company called Alkahest, which has separately studied plasma injections as a potential treatment for Alzheimer's.
And, Conboy says, there is no indication that the TIMP2 Castellano and colleagues detected in mouse brains actually came from the injections of human plasma. It's unclear, she says, whether a protein in plasma could actually make its way from a mouse's bloodstream into its brain, or that, once there, it could actually impact brain function.
Last year, Conboy published a study in which she and colleagues swapped half of the blood in old mice with that of young mice, and vice versa. They saw signs of regeneration in the muscles and liver.
But, says Conboy, "There was zero positive effect on the brain. The mice were not smarter. They did not learn better."
Such conflicting results reflect two fundamentally different ways of thinking about aging.
From the point of view of Castellano and colleagues, aging involves a loss of beneficial materials; for example, diminishing amounts of proteins that were once present in the plasma.
To Conboy, however, "The problem is not that you run out of positive things, but that you accumulate negative things."
She and others hold that proteins likely accumulate with old age, sometimes inhibiting certain functions, including the growth of new cells.
"We have hundreds of proteins that change with age," she says, and finding a way to reduce the effects of aging will likely require tinkering with a huge bouquet of them.
"If you are looking for miracles, it will not come from [injecting] bodily fluids," she says. "There will not be one silver bullet."
Original post:
Human Umbilical Cord Blood Helps Aging Mice Remember, Study Finds - NPR
Posted in Human Longevity
Comments Off on Human Umbilical Cord Blood Helps Aging Mice Remember, Study Finds – NPR
Valeant says its plaque psoriasis drug will cost $3500 a month – MarketWatch
Posted: at 12:23 am
Valeant Pharmaceuticals International VRX, -4.17% said early Friday that the company's new plaque psoriasis drug Siliq will cost $3,500 a month. Siliq, an injectable drug that Valeant got the rights for from AstraZeneca AZN, -0.47% is intended for patients with moderate-to-severe iterations of the chronic skin condition, who haven't responded to other medications. Valeant said the $3,500 price tag was "the lowest injectable biologic psoriasis treatment currently on the market" and was evaluated and approved by its Patient Access and Pricing Committee, which was created in May 2016 after a series of scandals, including one about drug pricing, rocked the company. Valeant expects to start selling and marketing Siliq starting in the second half of this year. Siliq's label will contain a "black box warning" about risks for patients with a history of suicidal thoughts or behavior. Valeant shares, which slumped 0.5% in premarket trade on Friday, have dropped 39.7% over the last three months, compared with a 3.7% rise in the S&P 500 SPX, -0.30%
Read more from the original source:
Valeant says its plaque psoriasis drug will cost $3500 a month - MarketWatch
Posted in Psoriasis
Comments Off on Valeant says its plaque psoriasis drug will cost $3500 a month – MarketWatch
‘It is not all gloomy if you’ve psoriasis’ – The Standard (press release)
Posted: at 12:23 am
Hellen Wangui ,28 years with a skin condition called Psoriasis she has been having for 13years.19th APRIL 2017 PHOTO DAVID GICHURU
She basked in her rosy glow during pregnancy and wished it could last forever. However, after the birth of her son, a skin condition she has battled since 2008 was back with a vengeance.
Hellen Wangui Gathere, 28, is suffering frompsoriasis, a condition that makes her skin appear dry, scaly and flaky on the legs, hands and back.
The Advocate of the High Court of Kenya is a member of thePsoriasisAssociation of Kenya that seeks to create awareness, champion for improved medical care and research on the disease.
"I choose to speak aboutpsoriasisbecause it is often misunderstood and persons with the condition stigmatised or prevented from participating in social activities," said the mother of a nine-month old boy.
Individuals with the condition are prone to heart disease, diabetes, obesity, heart attack, stroke and liver disease among other lifestyle diseases.
Psoriasisis not contagious, however, if not properly managed, it can lead to heart complications like hardening and narrowing of artery walls, diabetes and arthritis.
These underlying complications worried Wangui when she was pregnant with her first child last year.
Its an unpredictable scenario when a person withpsoriasisis pregnant because it can either improve, worsen or remain unchanged.
Luckily, pregnancy favoured Wangui, the condition was suppressed leaving a flawless youthful skin.
My skin took a different turn.Psoriasisdisappeared leaving me with an even-toned skin. It felt great to have smooth skin that I could rub without the dry and scaly feel, said Wangui in an interview with Saturday Standard.
On the advice of her dermatologist, she discontinued the oral medicines and ointments that had become a daily routine before pregnancy.
For a while, I forgot aboutpsoriasisand concentrated on my pregnancy that was also trouble-free, she added.
But after delivery,psoriasiswas back and she had to start a regime of oral medicines, ointments and phototherapy.
It is not all gloomy because I know how to take care of my skin to prevent flares. I am more concerned about a young lady or man too embarrassed to admit that they have psoriaisis and take an extra step to seek medical assistance, said Wangui.
The World Health Organisation (WHO) describespsoriasisas a chronic, painful, disfiguring, disabling and incurable disease.
Consultant skin specialist Hoseah Waweru describespsoriasisas a build up of new cells in the top layer of the skin, forming a scaly-like appearance.
These skin cells grow faster than your body can shed them off leaving thick red patches, says Dr Waweru. In 2014, he was part of a delegation to the 67th World Health Assembly urging the member states to recognisepsoriasisas a serious non communicable disease.
The resolution was adopted as World Health Assembly resolution WHA67.9 and it highlighted that many people in the world suffer needlessly frompsoriasisdue to incorrect or delayed diagnosis, inadequate treatment options and insufficient access to care, and because of social stigmatisation.
Though there are various types ofpsoriasis, Dr Waweru estimates that about one in every two persons have a type known as scalppsoriasiswhich has a silvery and powdery appearance, but very different from dandruff.
What causes this skin condition?
Though the causes of the condition remain largely unknown, it can be provoked by external and internal triggers, including mild trauma, sunburn, infections, medicines and stress.
Dr Evanson Kamuri, a dermatologist, said that the condition most likely runs in families. However, he advice's one to consult a skin specialist on medicines, both topical and oral, that are best suited for use during pregnancy.
Phototherapy, also known as light therapy uses specific wavelengths of light to help treatpsoriasis.
Wangui said this method is effective but expensive. I need two phototherapy sessions twice a week at Sh3,000 each besides oral medicines that cost Sh36,000 per month, she said.
Continue reading here:
'It is not all gloomy if you've psoriasis' - The Standard (press release)
Posted in Psoriasis
Comments Off on ‘It is not all gloomy if you’ve psoriasis’ – The Standard (press release)
Federal funding for basic research led to the gene-editing revolution. Don’t cut it. – Vox
Posted: at 12:22 am
Outside contributors' opinions and analysis of the most important issues in politics, science, and culture.
Labs across our country are a source of American optimism advancing knowledge, technologies, and cures. And yet, as citizens in 500 cities worldwide prepare to march this weekend in support of science, many American scientific practitioners are afraid. They worry that American science as we know it would be hobbled if President Trumps proposed 18 percent cut to the National Institutes of Health, Americas premier medical research funder, becomes reality.
We hope Congress will hear historys call and re-assert American leadership in advancing humanitys scientific knowledge.
Call us nave, but we believe as an immunologist and biochemist attempting to perfect and deploy gene-editing advances to cure disease that Democrats and Republicans alike can be united by a shared drive for scientific exploration and life-saving discoveries.
Science is not the property of any political party or region of the country. In red states and blues states, daughters and sons ask their first scientific questions when they come to us and wonder how the human body grows, how genes are inherited, and how a medicine works. Over the past century, American political leaders have encouraged young people to ask these fundamental questions, invested in their training to become scientists, and given them tools to translate questions into innovation.
The rewards of breakthroughs are felt most acutely when our families experience illness. Many of us know the pain of a loved one discovering a lump that turns out to be cancer or showing signs of neurological decline. In these moments, whatever our politics, we all hope to reach for the most powerful medicines, which continue to result from the relentless pursuit of scientific knowledge.
As we write, biomedical progress is accelerating, changing how we understand and fight disease. One example is CRISPR, a tool that can edit specific sequences in human DNA, which one of us helped invent and the other uses in research to understand and control the human immune system. Targeted at the building blocks of life, CRISPR could induce immune cells to fight disease or neutralize predisposition to one.
The combination of CRISPR and new therapies has raised hopes for a new generation of powerful cancer treatments. Across the US, our colleagues are teaming up and racing to apply similar approaches to dementia, heart disease, and countless other conditions.
A growing number of Americans have heard of CRISPR and its medical potential. Far fewer realize that the transformative applications of CRISPR genome editing would never have occurred without robust funding for basic scientific research. Inquiry into unusual genes in unglamorous bacteria before we even knew the gene-altering power they contained, laid the foundation for CRISPR technology. Now that same technology is driving a revolution in biomedicine and rapidly advancing towards clinical trials.
We certainly have not charted the breadth of microorganisms that will inspire the invention of future drugs, nor fathomed the full complexity of the inner workings of human cells. Thats the work of basic scientific research. The next revolution in biology is currently an idea in a scientists head, or being hashed out in a late night lab conversation among graduate students, or sitting in a grant application to the NIH asking for a chance.
Our research represents just a sliver of the vital projects that more than 300,000 researchers are undertaking in 50 states with NIH support. Unfortunately, the presidents proposed budget threatens that research. Among the deep cuts to science support he seeks is a nearly $6 billion reduction for NIH, representing nearly a fifth of the agencys funding. (For context, thats more than its entire current cancer budget.) The proposal has prompted justifiable concern among scientists and patient advocates. Funding cuts would deter tomorrows scientists from the field, or at least from pursuing careers in the US.
Curtailing the NIH budget, a significant chunk of Americas biomedical research funding, would cripple our capacity to lead on pressing health challenges. The vast majority of NIH funds go to funding scientific research and training, both within the agency and externally. For decades, America has been at the forefront of scientific innovation. Slashing funding would destroy long-term projects and threaten American primacy in medical research. More importantly, underfunding NIH will hamstring efforts to fight disease.
Some might argue that private industry will fill the void, given the economic benefits of scientific breakthroughs,. But the truth, surprising to many, is that while private investment can indeed lead to the discovery of profitable new drugs and therapies, its focus on the bottom line tends to short-change basic as opposed to applied research. In weighing a projects anticipated earnings and costs, businesses seek a probable path to profit.
Transformative science requires a different mold than the one found in industry. CRISPR grew not out of a race to develop disease treatments, but out of basic scientific research into bacteria. The boldest innovations stem from unlikely collaborations or quixotic investigations in other words, exploration driven by discovery rather than profit. Occasionally, these projects do become profitable, but only through a scientists persistent drive to show that an idea, a hope, a hunch, is not so crazy after all. While stockholders may not want a corporation to make bets that are unlikely to have an immediate payoff, as citizens we must demand our government does so.
And thats precisely why the National Institutes of Health exists: It ensures that, though we may not know what the next CRISPR will be, there are bright and dedicated American scientists pursuing many roads of inquiry, even if the path to profit isnt immediately clear.
As Congress considers the presidents budget, we have a simple request: Please give Americas scientists the tools we need to succeed.
Supporting NIH will position American scientists to continue the open-ended explorations at which they excel. Government funding is critical to encourage our scientists to pursue not just the challenges that are relatively easy, or obviously profitable, but the ones that are fiendishly hard yet crucial.
NIH funding is a down payment on discovery, the seed money to fund a critical step toward ending Alzheimers or curing cancer. What could be a bigger win for America than that?
Jennifer Doudna is a professor of chemistry, and molecular and cell biology, at the University of California, Berkeley. Alex Marson is an assistant professor of microbiology, immunology, and medicine at UC San Francisco.
The Big Idea is Voxs home for smart discussion of the most important issues and ideas in politics, science, and culture typically by outside contributors. If you have an idea for a piece, pitch us at thebigidea@vox.com
See the original post here:
Federal funding for basic research led to the gene-editing revolution. Don't cut it. - Vox
Posted in Gene Medicine
Comments Off on Federal funding for basic research led to the gene-editing revolution. Don’t cut it. – Vox
Scientists discover gene that blocks spread of colon cancer – Medical Xpress
Posted: at 12:22 am
April 21, 2017 by Jane Butler Cancer Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0
Researchers from RCSI (Royal College of Surgeons in Ireland) and the University of Nice, France, have discovered the function of a gene called KCNQ1 that is directly related to the survival of colon cancer patients. The gene produces pore-forming proteins in cell membranes, known as ion channels. The finding is an important breakthrough towards the development of more effective therapies for colon cancer and new diagnostics that will provide a more accurate prognosis for colon cancer patients. The research is published this week in the prestigious journal Proceedings of the National Academy of Sciences (PNAS).
This is the first study of its kind to work out the molecular mechanisms of how the KCNQ1 ion channel gene suppresses the growth and spread of colon cancer tumours.
Worldwide, there are 774,000 deaths from colorectal cancer each year and it is the third leading cause of death from cancer globally. In Ireland, almost 2,500 Irish people are diagnosed with bowel cancer annually and it is the second most common cause of cancer death.
The research team, led by Professor Brian Harvey, Department of Molecular Medicine, RCSI, have identified the molecular mechanisms by which the KCNQ1 gene suppresses the growth and spread of colon cancer cells. The KCNQ1 gene works by producing an ion channel protein which traps a tumour promoting protein called beta-catenin in the cell membranes before it can enter the nucleus of the cell causing more cancer cells to grow.
The study looked at the relationship between the expression of the KCNQ1 gene and patient survival from more than 300 colon cancer patients. Patients who had high expression of the KCNQ1 gene were found to have a longer survival and less chance of relapse.
Commenting on the significance of the discovery Professor Harvey said: "This study has demonstrated the ability of an ion channel gene to block the growth of colon cancer cells. This is an exciting discovery as it opens up the possibility of a new kind of therapy that will target the KCNQ1 gene with drugs and also as a biomarker to improve diagnostics of colon cancer onset and development in patients. This information will help clinicians to identify the most effective treatment for the individual patient."
"In the future, when we understand more about the KCNQ1 gene through further research, it will open up the possibility of developing new drug treatments that will be able harness the suppressive properties of the gene to target the colon specifically, without exposing other tissues in the body to unnecessary chemotherapy. The development of more targeted treatments for colon cancer is vital to improve the prognosis and quality of life for colon cancer patients."
Explore further: Among colon cancer patients, smokers have worse outcomes than non-smokers
More information: Raphael Rapetti-Mauss et al. Bidirectional KCNQ1:-catenin interaction drives colorectal cancer cell differentiation, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1702913114
In an analysis of more than 18,000 patients treated for colon cancer, current smokers were 14 percent more likely to die from their colon cancer within five years than patients who had never smoked.
Researchers from Boston University School of Medicine (BUSM) have discovered a possible strategy to treat colon cancers that are caused by the mutant KRAS gene, which is responsible for approximately half of all colon cancer ...
A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated. ...
Many types of cancer are caused by gene mutations in the signalling pathways that control cell growth, such as the hedgehog signalling pathway. A new study from the Karolinska Institutet, published in the journal Nature Communications, ...
Researchers from Oregon Health and Science University and Oregon State University have found that aspirin may slow the spread of some types of colon and pancreatic cancer cells. The paper is published in the American Journal ...
Researchers and physicians have grappled with the role of "adjuvant," or post-surgery, chemotherapy for patients with early-stage colon cancer, even for cancers considered high risk. Now researchers from the University of ...
Researchers from RCSI (Royal College of Surgeons in Ireland) and the University of Nice, France, have discovered the function of a gene called KCNQ1 that is directly related to the survival of colon cancer patients. The ...
A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. The study appears ...
A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
Cutting out certain amino acidsthe building blocks of proteinsfrom the diet of mice slows tumour growth and prolongs survival, according to new research published in Nature.
"Inhale deeply ... and exhale." This is what a test for lung cancer could be like in future. Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have developed a method that can detect the disease ...
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. Potential NSCLC patients usually undergo invasive tissue biopsy, which may ...
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Read the original here:
Scientists discover gene that blocks spread of colon cancer - Medical Xpress
Posted in Gene Medicine
Comments Off on Scientists discover gene that blocks spread of colon cancer – Medical Xpress
Game reviews: Bulletstorm: Full Clip Edition – Irish Independent
Posted: at 12:22 am
Which is precisely why Bulletstorm in this remastered version again proves so entertaining, an unending gory stream of kills performed in as inventive a fashion as possible. Never mind the plot, nor the sweary (and frankly wearing) script, this is a shooter as competitive sport, urging you to employ imaginative and eye-wateringly gruesome executions instead of just, y'know, killing enemies.
The sci-fi settings may be familiar (yet beautifully remastered) but it's the riotous score system that sets Bulletstorm on fire - why waste a bullet on an enemy when you can yank him from behind cover with a whip, then impale his body on to a spiky cactus? Or slide-tackle a guy and shove him into a lethal electric fence?
Yes, it's juvenile. No, graphics aside, it hasn't changed an iota from the 2011 original. But this overlooked gem deserves a new audience. Just not for anyone under the age of 18.
They don't make 'em like this any more. That's exactly why a group of ex-Rare alumni made this retro platformer with help from Kickstarter. It fills a gap in the market for colourful collect-'em-ups just like Rare used to excel at in the N64 days - see Banjo-Kazooie et al.
Inside the world of Yooka-Laylee - populated by wacky characters (one is called, ahem, Trowzer Snake) spouting wisecracks and built from familiar 3D platforming blueprints - it's as if the last 20 years in gaming never happened. Nostalgic fans will lap it up, though, entranced by its winning mix of cute animation, gentle (and fiendish) platforming and genre tropes. Newcomers may feel justifiably irked by its slightly loose controls, wonky camera and the lack of clear direction.
Developers are still figuring out what works best in virtual reality and Fated attempts a movie-length storyline, earthed in Norse mythology, accompanied by some light interaction.
It works, to a point, thanks to a cartoonish World of Warcraft-aesthetic and some engaging character designs as you try to save your wife and daughter from vengeful giants. But the lack of meaningful gameplay undermines Fated's attractive 10 price point.
See the original post:
Game reviews: Bulletstorm: Full Clip Edition - Irish Independent
Posted in Politically Incorrect
Comments Off on Game reviews: Bulletstorm: Full Clip Edition – Irish Independent